what is a glp-1/gip The activity of GLP-1 and GIP for Type 2 Diabetes and Obesity GLP-1 vs. GLP-1 + GIP:

The medication is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that works by enhancing glucose-dependent insulin secretion, suppressing glucagon release, and slowing gastric emptying

Revision surgeries are expensive and time consuming

One innovation getting attention is the transdermal GLP-1 patch

Pharmacol Rev 2003, 55: 167194

In a 48-week clinical trial, higher doses consistently led to greater average weight loss: Weight loss by dose (48-week clinical trial) In this trial, at the highest dose (12 mg), people lost an average 24% of their starting weight on average